Solution for single intraarticular injection
Fermatron Synovial fluid prosthesis:
restores visco-elastic and protective properties of the joint fluid
reduces inflammatory reactions
increases joint mobility
restores homeostasis in the cartilage
stimulates the synthesis of hyaluronic acid
is indicated for any stage of osteoarthritis and after arthrocopy administered intraarticularly with an interval of 7 days
long-term effect and the absence of side effects
the only contraindication Fermathron use: infection in the injection area.
For analgesia and improved mobility of the knee joint and other synovial joints in patients with mild or moderate osteoarthrosis, caused by degenerative changes or traumatic injuries of the synovial joint.
Do not administer Fermatron plus for inflammation or for signs of skin diseases at the injection site, hypersensitivity to sodium hyaluronate.
Use during pregnancy and lactation
The safety of the use of the drug Fermatron plus during pregnancy and lactation has not been established. The appointment of the drug during pregnancy and lactation at the discretion of the orthopedic surgeon.
Do not use if washing packaging is damaged. Sodium hyaluronate is obtained by fermentation of Streptococcus equi bacteria and thoroughly cleaned. However, the physician must take into account the immunological effects and potential risks associated with the injection of any biological substance. Sterile product is for single use only. Follow instructions for safe use and disposal of needles. In case of injury, consult a doctor immediately. Not intended for children.
2 ml solution contains:
Active ingredient: sodium hyaluronate 20 mg
Dosage and administration
The drug should be administered only by medical professionals, special training. The recommended dose is the introduction into the cavity of the affected synovial joint once a week from one to three injections, depending on the severity of osteoarthritis. For patients with osteoarthritis of the knee joints of mild or moderate severity, it is recommended to inject 2.0 ml of the drug into the synovial cavity of the knee joint once a week for 1-3 weeks.
With intra-articular administration, temporary passing pain and swelling are possible.
In patients with inflammatory osteoarthritis after administration of the drug, synovial joint inflammation may temporarily increase.
In rare cases, an inflammatory reaction is possible, which may or may not be associated with the introduction of Fermatron.
Compatibility of the simultaneous intra-articular administration of the drug Fermatron plus with other substances was not tested. Therefore, mixing or simultaneous administration of others inside the joint preparations is not recommended.
Store in a dark place at 2 ° C to 25 ° C. Do not freeze.
Prescription terms from
Form of Treatment
simply entails dlya inaektsiy
HajÃ©ltek, United Kingdom